Pacifica Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Pacifica Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10	Closed	-$2K	–	500
2021 Q1	$2K	Hold	10	–	–	﹤0.01%	387
2020 Q4	$1K	Hold	10	–	–	﹤0.01%	381
2020 Q3	$1K	Hold	10	–	–	﹤0.01%	343
2020 Q2	$1K	Hold	10	–	–	﹤0.01%	370
2020 Q1	$1K	Hold	10	–	–	﹤0.01%	366
2019 Q4	$1K	Buy	+10	New	+$1.12K	﹤0.01%	360

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Pacifica Partners's GWPH Position: Q2 2021 in Review

Pacifica Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 10 shares — an estimated $2K sold.

Pacifica Partners first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $2K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Pacifica Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Pacifica Partners sold 10 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2K.
Pacifica Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
Pacifica Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Pacifica Partners's 13F filing for Q2 2021, filed 14 Jul 2021.